Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

China flag China · Delayed Price · Currency is CNY
6.21
+0.03 (0.49%)
Apr 15, 2026, 3:08 PM CST
Market Cap6.56B +64.3%
Revenue (ttm)775.69M -2.5%
Net Income-134.71M
EPS-0.13
Shares Out1.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume91,175,134
Average Volume69,076,600
Open5.86
Previous Close6.18
Day's Range5.86 - 6.32
52-Week Range3.20 - 6.65
Beta0.26
RSI65.63
Earnings DateMar 19, 2026

About SHE:300006

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 973
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300006
Full Company Profile

Financial Performance

In 2025, SHE:300006's revenue was 775.69 million, a decrease of -2.50% compared to the previous year's 795.60 million. Losses were -134.71 million, 53.4% more than in 2024.

Financial Statements